Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Insulin pen
by Highest Patent Value in the world in 2018

The Insulin pen top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Insulin pen Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985.
#
Company Name
Region
Tech Topics
Total
1
United Kingdom
Insulin pen,Insulin injection,Health care,
...[+2]
Avg patent value: 3.29 M
2
Haryana, India
Medical equipment,Health care,Surgical Specialty,
...[+2]
Avg patent value: 2.38 M
3
Dublin, Ireland
Avg patent value: 2.38 M
4
Avg patent value: 2.36 M
5
Hessen, Germany
Avg patent value: 2.20 M
6
Avg patent value: 2.19 M
7
Switzerland
Medicine,Health care,Drug,
...[+2]
Avg patent value: 792,400
8
Avg patent value: 420,000
9
Avg patent value: 406,000
10
United Kingdom
Human resources,Recruitment Activity
Avg patent value: 290,000
11
Hovedstaden, Denmark
Insulin,Health care,Haemophilia,
...[+2]
Avg patent value: 116,555
12
Avg patent value: 110,000
13
Avg patent value: 100,000
14
Avg patent value: 53,000
15
Avg patent value: 52,300
16
Medical equipment,Health care,Production function,
...[+1]
Avg patent value: 51,500
17
Baden-Wurttemberg, Germany
Avg patent value: 31,000
18
Gyeonggi-do, South Korea
Avg patent value: 21,000
19
Avg patent value: 4,300
20
Nordrhein-Westfalen, Germany
Health care,Diabetes Therapy,Immunoprotein,
...[+2]
Avg patent value: 3,700
Page generation time: Apr 27 2025